Nicolas Derome is a professor of Biology at Laval University in Québec. He specializes in natural immunity and the interaction of humans with microbes in their environment.
In the following video Dr. Derome discusses medical and ethical issues of injecting children with the experimental mRNA treatment that is intended to mitigate the effects of infection with the Wuhan Coronavirus. He is at pains to point out that no children from 5 to 11 years old were included in the phase 3 clinical trials of the “vaccines”, so that nothing is known about their long-term adverse effects on young children.
Many thanks to MissPiggy for the translation, and to Vlad Tepes and RAIR Foundation for the subtitling:
Video transcript:
| 00:05 | So, hello, my name is Nicolas Derome. | |
| 00:08 | I’m a Professor in the Biology Department at Laval University, | |
| 00:12 | and to introduce myself, by telling you about my background. | |
| 00:17 | I have a master’s degree in molecular engineering | |
| 00:21 | that I completed at the Muséum National D’histoire Naturelle in Paris, | |
| 00:27 | then I did a Ph.D. in population genetics at the Pierre et Marie Curie University in Paris, | |
| 00:34 | and then I crossed the Atlantic for a post-doctoral internship at Laval university. | |
| 00:39 | What I’m most interested in is something called functional genomics. | |
| 00:43 | What does that mean? I got interested in gene expression | |
| 00:47 | in fish and therefore in RNA. Messenger RNA. | |
| 00:51 | I applied to become a professor in the biology department, | |
| 00:57 | and I specialized in the interactions between animals and the whole community of microbes | |
| 01:04 | that live in symbiosis with them. And more particularly, what interests us, the laboratory team, | |
| 01:11 | is understanding how these beneficial microbes can help the higher organisms, animals, | |
| 01:18 | to remain in good health, resistant to the attack of diseases. | |
| 01:24 | In this study, we developed probiotic approaches | |
| 01:28 | by isolating microbes within the organism in good health. | |
| 01:32 | We cultivated them and then re-administered them, | |
| 01:36 | which then confers a natural protection against the diseases. | |
| 01:40 | So I would like to address you on another level, being as that I am a father as well, | |
| 01:47 | a father of three boys. I was invited by Ray Foucault (?) | |
| 01:53 | because I wanted to communicate | |
| 01:58 | some information that I consider very important about the experimental vaccination | |
| 02:04 | for children from 5 to 11 years old, which is a hot topic at the moment. | |
| 02:08 | This information that I consider very important vital to have | |
| 02:12 | in order to make a free and informed choice about this vaccination campaign, | |
| 02:21 | which is now intended for children from 5 to 11 years old. | |
| 02:27 | The presentation I’m doing is very simple and is based on three major questions | |
| 02:34 | in relation to this experimental vaccination. Is it useful? Is it recommendable? | |
| 02:41 | Finally, is it even legal or ethical? | |
| 02:47 | First of all, I would like to tell you that according to the INSPQ in Quebec, | |
| 02:53 | there have been no serious cases related to Covid in children under 17 years old, | |
| 02:59 | even up to 19 years old, and I can even tell you | |
| 03:04 | that the mortality rate on a worldwide scale | |
| 03:09 | is extremely low. As you see here, it’s two per million. | |
| 03:14 | .0002% which represents one death out of five hundred thousand children. OK? | |
| 03:21 | That means that the risk is 15 times lower than the risk of road accidents for children | |
| 03:26 | between the ages of 1 and 14, according to current data in Canada. | |
| 03:32 | The fact is that children, compared to adults, have a very different immune response to this virus. | |
| 03:41 | Essentially, they will use their innate immunity. Meaning, the one in which they were born with, | |
| 03:48 | and the reason for their very low mortality rate. | |
| 03:54 | This is due to it being far more effective than the one in adults. | |
| 03:58 | The last point, which seems to me just as essential: | |
| 04:04 | it is very well documented that the transmission of the SARS-CoV-2 virus responsible for COVID 19 | |
| 04:10 | is mainly transmitted from adults to children. | |
| 04:16 | Child to adult virus transmission is extremely rare. | |
| 04:23 | So is it recommended? Well, according to the W.H.O. | |
| 04:27 | this experimental vaccination is not recommended | |
| 04:30 | for children under the age of 18, and we will see what the reasons are. | |
| 04:36 | Finally, is this experimental vaccination illegal or even ethical? | |
| 04:43 | The first thing that we must keep in mind is that if I use the term “experimental,” | |
| 04:47 | it’s because this treatment is in a phase of experimentation. | |
| 04:54 | It’s in phase 3 of clinical trials. | |
| 04:59 | Currently, the third phase of these studies for the Moderna and Pfizer vaccines, as you see, | |
| 05:06 | will be completed in October 2022 (for Moderna) and May 2023, respectively. | |
| 05:11 | Because this experimental vaccination makes use of messenger RNA, | |
| 05:18 | which makes it in fact a kind of gene therapy. | |
| 05:22 | So, it’s an experimental gene therapy, which even the President of Bayer, | |
| 05:28 | which is a leader in the pharmaceutical industry, admitted in a statement that RNA vaccines | |
| 05:33 | are an example of gene therapy. More recently, the president of the Pfizer group | |
| 05:42 | stated that messenger RNA injections are a tool meant to edit genes. | |
| 05:50 | So is it ethical? Until now, children have not been included | |
| 05:56 | in conclusive clinical trials. | |
| 06:00 | Meaning, these trials can give me an idea of the effectiveness and safety of these treatments | |
| 06:09 | in the short, medium and long term. | |
| 06:14 | According to the WHO, for children under 16 years of age, it recognizes that there is an absence | |
| 06:19 | of convincing efficacy data, as I was saying, in the short, | |
| 06:22 | medium and long term, and the same applies to safety. | |
| 06:25 | You have certainly heard about the FDA trial, the American agency, | |
| 06:31 | but it appears that the number of people used in this study | |
| 06:35 | is much too small to detect the side effects | |
| 06:39 | that are currently documented in adolescents, such as myocarditis. | |
| 06:45 | The size of this trial for 5 to 11 year olds included 2500 children that were injected. | |
| 06:52 | In Ontario, it is known that there is a risk of one in five thousand | |
| 06:56 | of having myocarditis as a side effect. | |
| 07:00 | Myocarditis is an infection of the heart, which is very problematic. | |
| 07:06 | So, the study currently available does not show | |
| 07:12 | what the rate of side effects will be. | |
| 07:16 | So now what I’ll present will take us into a little more detail. | |
| 07:20 | I will present to you reference data, which is data that has been published in scientific journals, | |
| 07:27 | peer-reviewed, meaning it is examined by other researchers, independent researchers, | |
| 07:33 | who validate or don’t validate the results. | |
| 07:37 | When the article is published, then you know with certainty that all results have been validated. | |
| 07:45 | So here, the prevalence children vs. adults. What does that mean? Well, it means | |
| 07:50 | the prevalence of the disease. Do children have more or less disease than adults? | |
| 07:57 | There’s a very good study which was made in the United Kingdom with 12 million children. | |
| 08:01 | You see it’s a very important study that made it possible to establish that | |
| 08:07 | the mortality rate was extremely low. | |
| 08:11 | In Quebec, the INSPQ shows that there were no deaths for 5- to 19-year-olds | |
| 08:20 | since the beginning of the pandemic. Other studies, in other countries, | |
| 08:24 | such as China and the United States shows that in children under 10 years of age, | |
| 08:29 | around 1% of children were infected and other studies show even lower percentages. | |
| 08:36 | Further studies show even lower results, as in Iceland, where there were no children infected. | |
| 08:41 | By “infected”, that doesn’t necessarily mean sick. It could also mean, carrier of the virus. | |
| 08:46 | Another example is the city of Vo in Italy. | |
| 08:50 | Even if it is a smaller study, it still confirms that the infection rates are extremely low. | |
| 08:56 | The last point in this section is that in adults, we know that co-morbidities are very aggravating | |
| 09:04 | factors with the Covid-19 disease. Only the adults with pathologies such as cancers, renal failure, | |
| 09:13 | autoimmune disorders, etc., were much more likely to die if they catch the disease, | |
| 09:20 | than those who do not have these pre-existing conditions. Studies have shown that in children | |
| 09:24 | with co-morbidities the impact is extremely low. | |
| 09:28 | Moreover, in Quebec even including the children with co-morbidities, there was not one death. | |
| 09:36 | Finally, a very important point, which is | |
| 09:41 | the notion of transmission of the disease, | |
| 09:46 | which is an argument for those defending vaccination in children. The argument is made that | |
| 09:50 | children transmit the virus and there is risk of transmitting it to adults and other children. | |
| 09:54 | The scientific results linked to data show that this is not true. | |
| 09:59 | As you see, 95% of the infectious outbreaks are linked to adults, | |
| 10:04 | which means that they were initiated by an infected adult. | |
| 10:08 | Another study that focused on a fairly large population showed that there was no transmission | |
| 10:17 | from an infected child to an adult. This was a studied based on nine infected children | |
| 10:24 | by following up on 863 contacts, and the same study focused on nine infected adults. | |
| 10:32 | Essentially it was the adults who infected the children. | |
| 10:39 | The article in the review was published in 2020, | |
| 10:44 | which shows that children aren’t transmitters | |
| 10:49 | and do not transmit the SARS-CoV-2 virus. | |
| 11:01 | The natural resistance for children against this disease, as we saw earlier | |
| 11:08 | that the natural immunity of children is different from that of adults and above all, | |
| 11:12 | it is more efficient, as shown by their much lower infection rate, | |
| 11:16 | and their extremely low mortality rate. | |
| 11:20 | So they essentially use a strong innate immune response. | |
| 11:25 | This innate immune response is non-specific, but allows them to defend themselves | |
| 11:34 | against a large panel of diverse pathogens. For a little more detail, | |
| 11:40 | it has been shown that in children it is essentially | |
| 11:44 | the Interleukin 17A which activates the immune system, | |
| 11:48 | which expresses itself within the immune system, as well as, Interferon Gamma. | |
| 11:54 | Both are tools used to fight against viral infections. | |
| 11:58 | In terms of response, that is to say, from the development | |
| 12:02 | of specific antibodies for a given pathogen, | |
| 12:06 | in this case with SARS-CoV-2, in children there’s only one kind of antibody. | |
| 12:13 | The immunoglobulins G is used against the protein spike S or spicules, if you will. | |
| 12:20 | While in adults the response to the infection to the SARS-CoV-2 is much more complex, | |
| 12:29 | implementing different types of antibodies. So, designates immunoglobulin type A, M and type G | |
| 12:36 | against the spike protein, but also, immunoglobulins A work against another protein of the virus, | |
| 12:45 | the nucleocapsid protein. This shows | |
| 12:50 | that the natural immunity in adults has other antibodies | |
| 12:56 | compared to what is produced by the experimental injection. | |
| 13:02 | All this is to say that children have an immune response very different from the parents | |
| 13:09 | and that it does not appeal to the specific antibodies. | |
| 13:13 | This raises the question does the vaccine approach | |
| 13:17 | risk being simply ineffective? | |
| 13:24 | So, it is not recommended and this is what the W.H.O. says. This is a screenshot taken directly | |
| 13:29 | from the UNICEF website and it shows | |
| 13:34 | in relation to the use of these experimental vaccines | |
| 13:39 | in children under 16 to 18 years. | |
| 13:43 | As you see here, these treatments are not recommended | |
| 13:47 | for people under the age of 16 to 18 years old. | |
| 13:51 | Even if they belong to a high risk group. So that means, even for children with co-morbidities | |
| 13:59 | who could have a greater risk of infection than children without co-morbidity. | |
| 14:04 | Another very important point is that children | |
| 14:07 | weren’t included in the initial trials of the vaccines | |
| 14:10 | against Covid-19. That means, the famous phase 3 study that I mentioned earlier, which ends in 2022 | |
| 14:16 | for Moderna and in 2023 for Pfizer. From an ethical point of view, | |
| 14:23 | there is little or no data on the safety or efficacy of these vaccines for children under 16 years. | |
| 14:30 | No convincing data. I will come back to this. We talked about it earlier. | |
| 14:36 | The W.H.O. states that further research is absolutely necessary | |
| 14:41 | to validate these treatments for children | |
| 14:45 | under 16 or 18 years of age. Meaning the age group of 5 to 11 years old, which interests us today. | |
| 14:53 | In terms of the efficacy of these experimental vaccines, the recent data for adults and adolescents | |
| 15:01 | for which we now have some hindsight is, | |
| 15:04 | well, according to the admission of Anthony Fauci, director | |
| 15:08 | of the CDC in the United States, the agency which controls diseases | |
| 15:12 | and the equivalent of Health Canada, | |
| 15:15 | which was published in an article in The Lancet, | |
| 15:19 | one of the most prestigious publications in biomedical research. | |
| 15:23 | This study shows that the experimental vaccines | |
| 15:26 | do not protect durably against the serious forms of illness, | |
| 15:30 | nor do they prevent death. | |
| 15:34 | The other point that is important is that these experimental vaccines do not reduce the viral load | |
| 15:42 | in adolescents and adults. By comparing the viral loads of infected vaccinated individuals with | |
| 15:49 | those in unvaccinated individuals the researchers actually observed that the viral loads | |
| 15:57 | were the same. In conclusion, these vaccines are not effective in reducing transmission | |
| 16:05 | and infection in adolescents or adults. So here again, these three essential points show | |
| 16:14 | that these experimental vaccines are not as effective as expected at the beginning of this | |
| 16:20 | phase 3 of experimentation. They show us that children | |
| 16:26 | have a different form of immune defenses, | |
| 16:31 | different from those of the adolescents and the adults, | |
| 16:35 | and, well, it is unlikely that these vaccines | |
| 16:38 | will be effective in children. Once again, I remind you, very few children become sick [with Covid] | |
| 16:45 | and they especially do not have any serious form of the disease. | |
| 16:49 | This is the conclusion of the information that I wanted to convey to you today. | |
| 16:55 | All the references are available. I think this slide show will be posted online. | |
| 17:01 | In the last slide, I showed detailed references. I will present them to you in overview. | |
| 17:06 | Here are references upon which I based this presentation to convey this information to you. | |
| 17:14 | Thank you for your attention. Please take care of yourselves and your children. | |
| 17:19 | If you are a scientist, academic or researcher and wish to join | |
| 17:22 | us, please visit our website: reinfocovid.ca |
What did Jesus say, anyone who harms a child, it is better he had a millstone hung around his neck and thrown into the the deepest Ocean.